Biotech Acquisition Company and Blade Therapeutics Announce Postponement of Extraordinary Meeting of Shareholders to Approve Proposed Business Combination
yahoo.com
science
2022-05-31 11:30:00

Extraordinary General Meeting of BAC's shareholders postponed until June 3, 2022, at 10:00 a.m., Eastern Time

NEW YORK and SOUTH SAN FRANCISCO, May 31, 2022 /PRNewswire/ -- Biotech Acquisition Company (NASDAQ: BIOT) ("BAC"), a publicly traded special purpose acquisition company affiliated with SPRIM Global Investments, and Blade Therapeutics, Inc. ("Blade"), a biopharmaceutical company based in South San Francisco, Calif., today announced the postponement of BAC's extraordinary general meeting of shareholders (the "Extraordinary Meeting") originally scheduled to be held on June 1, 2022.
